文献速递角膜与眼表疾病白内障与屈光手术

双氯芬酸与双氯芬酸联合瑞巴派特白内障术后结膜杯状细胞密度:一项随机试验

Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial.
PubMed 文献 · Am J Ophthalmol · 2017-06-29

这项随机临床试验纳入80例拟行白内障手术患者,比较术后单用双氯芬酸、双氯芬酸联合瑞巴派特、单用倍他米松、倍他米松联合瑞巴派特对结膜杯状细胞密度的影响。结果显示双氯芬酸组杯状细胞密度显著下降,联合瑞巴派特可阻断该下降。

要点

  • 双氯芬酸组杯状细胞密度从术前257.0±188.7 cells/mm2显著降至术后1个月86.5±76.7 cells/mm2(P = .002)。
  • 双氯芬酸联合瑞巴派特组术前238.5±116.6 cells/mm2与术后1个月211.3±184.4 cells/mm2无统计学差异(P = .55)。
  • 倍他米松组和倍他米松联合瑞巴派特组术后1个月杯状细胞密度下降但无显著差异(P = .11和P = .52)。

核心结论

  • 白内障术后局部使用双氯芬酸使结膜杯状细胞密度显著降低,联合使用局部瑞巴派特可阻断该降低。

研究设计与样本

  • 随机临床试验,纳入80例拟行白内障手术患者,随机分为4组:A组单用双氯芬酸、B组双氯芬酸联合瑞巴派特、C组单用倍他米松、D组倍他米松联合瑞巴派特。
  • 术前及术后1个月行印迹细胞学检查,测定杯状细胞平均密度。

主要发现

  • A组术前杯状细胞密度257.0±188.7 cells/mm2,术后1个月显著降至86.5±76.7 cells/mm2(P = .002)。
  • B组术前238.5±116.6 cells/mm2与术后1个月211.3±184.4 cells/mm2无统计学差异(P = .55)。
  • C组和D组术后1个月杯状细胞密度下降但无显著差异(P = .11和P = .52)。

临床怎么用

  • 作者认为,局部瑞巴派特与非甾体抗炎药联合使用有益,尤其对于术后干眼病例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the effects of topical diclofenac or betamethasone with concomitant application of topical rebamipide on the conjunctival goblet cell density in eyes after cataract surgery. DESIGN: Randomized clinical trial. PARTICIPANTS: Eighty patients who were scheduled for cataract surgery. METHODS: Patients were randomized into 4 groups according to the postoperative topical drugs to be given; Group A, diclofenac alone; Group B, diclofenac and rebamipide; Group C, betamethasone alone; and Group D, betamethasone and rebamipide. Impression cytology was performed before and at 1 month after the surgery, and the mean density of goblet cells was determined. RESULTS: The mean (± SD) density of goblet cells before the surgery in Group A was 257.0 ± 188.7 cells/mm2, and it decreased significantly to 86.5 ± 76.7 cells/mm2 at 1 month after the surgery (P = .002). In Group B, the goblet cell density was not statistically different between before (238.5 ± 116.6 cells/mm2) and at 1 month after the surgery (211.3 ± 184.4 cells/mm2, P = .55). In Groups C and D, the mean density of goblet cells was decreased at 1 month after the surgery, but the decreases were not significant (P = .11 and P = .52, respectively). CONCLUSION: After cataract surgery with postoperative topical diclofenac, the conjunctival goblet cell density was significantly reduced, and this reduction was blocked by the concomitant use of topical rebamipide. These results suggest that the concomitant use of topical rebamipide with nonsteroidal anti-inflammatory drugs is beneficial, especially in cases with postoperative dry eyes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kato K, Miyake K, Kondo N, et al. Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial. Am J Ophthalmol. 2017. PMID: 28669778. doi:10.1016/j.ajo.2017.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。